Ascelia Pharma
ACE | ST
Overview
Corporate Details
- ISIN(s):
- SE0010573113 (+2 more)
- LEI:
- 5493002YR9VCJJPWYN08
- Country:
- Sweden
- Address:
- Hyllie Boulevard 34, 215 32 Malmö
- Website:
- https://www.ascelia.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. The company has two drug candidates – Orviglance® (former working name Mangoral) and Oncoral – in clinical development. About Orviglance (Mangoral) Orviglance* (manganese chloride tetrahydrate) is a novel oral contrast agent for MR-imaging developed to improve the detection and visualization of focal liver lesions (including liver metastases and primary tumors) in patients with reduced kidney function. About Oncoral Oncoral is a novel oral irinotecan tablet in development. Irinotecan is a chemotherapy with established potent anti-tumor effect – even in difficult to treat cancers. Oncoral is a daily tablet with the potential to offer better patient outcomes with improved safety following a daily tablet treatment compared to intravenous high-dose infusions at the hospital.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-16 07:30 |
Interim Report
|
Swedish | 4.4 MB | |
| 2025-05-16 07:30 |
Interim Report
|
English | 4.4 MB | |
| 2025-05-07 16:30 |
Declaration of Voting Results & Voting Rights Announcements
Kommuniké från årsstämma den 7 maj 2025 i Ascelia Pharma AB
|
Swedish | 193.2 KB | |
| 2025-05-07 16:30 |
Declaration of Voting Results & Voting Rights Announcements
Bulletin from the Annual General Meeting in Ascelia Pharma AB on 7 May 2025
|
English | 192.7 KB | |
| 2025-04-30 11:30 |
Declaration of Voting Results & Voting Rights Announcements
Change in Number of Shares and Votes in Ascelia Pharma AB
|
English | 185.4 KB | |
| 2025-04-30 11:30 |
Declaration of Voting Results & Voting Rights Announcements
Ändring av antalet aktier och röster i Ascelia Pharma AB
|
Swedish | 185.6 KB | |
| 2025-03-18 22:05 |
Regulatory News Service
Ascelia Pharma meddelar positivt utfall från FDA-möte och bekräftar planen att …
|
Swedish | 190.7 KB | |
| 2025-03-18 22:05 |
Regulatory News Service
Ascelia Pharma Announces Positive Outcomes of FDA Meeting and Confirms Plan to …
|
English | 190.5 KB | |
| 2025-02-25 14:45 |
Declaration of Voting Results & Voting Rights Announcements
Kommuniké från extra bolagsstämma den 25 februari 2025 i Ascelia Pharma AB
|
Swedish | 191.1 KB | |
| 2025-02-25 14:45 |
Declaration of Voting Results & Voting Rights Announcements
Bulletin from the Extraordinary General Meeting in Ascelia Pharma AB on 25 Febr…
|
English | 190.5 KB | |
| 2025-02-12 21:30 |
AGM Report
Nomination Committee Appointed for AGM 2025 in Ascelia Pharma AB
|
English | 191.2 KB | |
| 2025-02-12 21:30 |
General Meeting Notice
Valberedning utsedd i Ascelia Pharma AB inför årsstämman 2025
|
Swedish | 191.0 KB | |
| 2025-02-07 07:30 |
Earnings Release
|
Swedish | 4.0 MB | |
| 2025-02-07 07:30 |
Annual Report
|
English | 4.1 MB | |
| 2025-01-30 13:45 |
General Meeting Notice
KALLELSE TILL EXTRA BOLAGSSTÄMMA I ASCELIA PHARMA AB
|
Swedish | 221.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-22 | Marie Birgitta Källström | Other | Other | 18,752 | 40,316.80 SEK |
| 2025-04-15 | Niels Mengel | Other | Other | 92,304 | 198,453.60 SEK |
| 2025-04-15 | Peter Benson | Other | Other | 50,000 | 107,500.00 SEK |
| 2025-04-15 | Carin Linde | Other | Other | 40,328 | 86,705.20 SEK |
| 2025-04-15 | Peter Benson | Other | Other | 21,688 | 46,629.20 SEK |
| 2025-04-15 | Peter Benson | Other | Other | 20,472 | 44,014.80 SEK |
| 2025-04-15 | Julie Brogren | Other | Other | 18,000 | 38,700.00 SEK |
| 2025-04-15 | Peter Benson | Other | Other | 6,152 | 13,226.80 SEK |
| 2024-09-03 | KIBEGEON | Other | Sell | 913,545 | 150,917.63 SEK |
| 2024-09-03 | Niels Mengel | Other | Sell | 131,965 | 17,815.28 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |